M&A Deal Summary

Catalyst Biosciences Acquires Targacept

On March 5, 2015, Catalyst Biosciences acquired life science company Targacept

Acquisition Highlights
  • This is Catalyst Biosciences’ 1st transaction in the Life Science sector.
  • This is Catalyst Biosciences’ 1st transaction in the United States.
  • This is Catalyst Biosciences’ 1st transaction in North Carolina.

M&A Deal Summary
Date 2015-03-05
Target Targacept
Sector Life Science
Buyer(s) Catalyst Biosciences
Deal Type Merger
Advisor(s) Stifel, Nicolaus & Co., Inc. (Financial)
Mintz Levin Cohn Ferris Glovsky and Popeo PC (Legal)

Target

Targacept

Winston-Salem, North Carolina, United States
Targacept is a R&D pharmaceutical company. Targacept is involved with the development and commercialization of drugs based on selective activation of a previously unexploited class of targets - neuronal nicotinic acetylcholine receptors (NNRs). These drugs offer a new way to treat various major CNS and gastrointestinal diseases and disorders including Alzheimer's Disease, depression and ulcerative colitis.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Catalyst Biosciences

San Francisco, California, United States
Category Company
Founded 2002
Sector Life Science
DESCRIPTION

Catalyst Biosciences, Inc. is a privately held biotechnology company focused on engineering and developing novel therapeutic protease products.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Merger) 1 of 1
State (North Carolina) 1 of 1
Country (United States) 1 of 1
Year (2015) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-24 Catalyst Biosciences - Protease Medicines

San Francisco, California, United States

Catalyst Biosciences' Protease Medicines that regulate complement, including CB 2782-PEG. Catalyst Biosciences' Protease Medicines is based in San Francisco, California.

Sell $60M
Mergr

Product

Company

Legal